Catalyst Wire Dossier Catalyst Wire Dossier

Glucose-Insulin-Potassium Therapy

glucose-insulin-potassium
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Glucose-Insulin-Potassium Therapy, covering 2018-05-11 to 2018-05-11. Get the full timeline:

Most recent: Clinical Trial Update: Glucose-insulin-potassium Therapy Improves Lactic Acidosis in Liver Transplantation [NA]

See pricing